Long non-coding RNA-PCGEM1 contributes to prostate cancer progression by sponging microRNA miR-129-5p to enhance chromatin licensing and DNA replication factor 1 expression

References

• Bray F, Ferlay J, Soerjomataram I, et al. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018;68(6):394–424.
   PubMed Web of Science ®Google Scholar
• Pernar CH, Ebot EM, Wilson KM, et al. The epidemiology of prostate cancer. Cold Spring Harb Perspect Med. 2018;8(12):a030361.
   PubMed Web of Science ®Google Scholar
• Rawla P. Epidemiology of prostate Cancer. World J Oncol. 2019;10(2):63–89.
   PubMedGoogle Scholar
• Eeles R, Goh C, Castro E, et al. The genetic epidemiology of prostate cancer and its clinical implications. Nat Rev Urol. 2014;11(1):18–31.
   PubMed Web of Science ®Google Scholar
• Ali T, Grote P. Beyond the RNA-dependent function of LncRNA genes. eLife. 2020;9. DOI:10.7554/eLife.60583
   Web of Science ®Google Scholar
• Hua JT, Chen S, He HH. Landscape of noncoding RNA in prostate Cancer. Trends Genet. 2019;35(11):840–851.
   PubMed Web of Science ®Google Scholar
• Walsh AL, Tuzova AV, Bolton EM, et al. Long noncoding RNAs and prostate carcinogenesis: the missing ‘linc’? Trends Mol Med. 2014;20(8):428–436.
   PubMed Web of Science ®Google Scholar
• Ho TT, Huang J, Zhou N, et al. Regulation of PCGEM1 by p54/nrb in prostate cancer. Sci Rep. 2016;6(1):34529.
   PubMedGoogle Scholar
• Fu X, Ravindranath L, Tran N, et al. Regulation of apoptosis by a prostate-specific and prostate cancer-associated noncoding gene, PCGEM1. DNA Cell Biol. 2006;25(3):135–141.
   PubMed Web of Science ®Google Scholar
• Wang JY, Yang Y, Ma Y, et al. Potential regulatory role of lncRNA-miRNA-mRNA axis in osteosarcoma. Biomed Pharmacothe. 2020;121:109627.
   PubMed Web of Science ®Google Scholar
• Xu C, Du Z, Ren S, et al. MiR-129-5p sensitization of lung cancer cells to etoposide-induced apoptosis by reducing YWHAB. J Cancer. 2020;11(4):858–866.
   PubMed Web of Science ®Google Scholar
• Wu Q, Meng WY, Jie Y, et al. LncRNA MALAT1 induces colon cancer development by regulating miR-129-5p/HMGB1 axis. J Cell Physiol. 2018;233(9):6750–6757.
   PubMed Web of Science ®Google Scholar
• Gao G, Xiu D, Yang B, et al. miR-129-5p inhibits prostate cancer proliferation via targeting ETV1. Onco Targets Ther. 2019;12:3531–3544.
   PubMedGoogle Scholar
• Zhang T, Piao HY, Guo S, et al. LncRNA PCGEM1 enhances metastasis and gastric cancer invasion through targeting of miR-129-5p to regulate P4HA2 expression. Exp Mol Pathol. 2020;116:104487.
   PubMed Web of Science ®Google Scholar
• Li Q, Shen F, Zhao L. The relationship between lncRNA PCGEM1 and STAT3 during the occurrence and development of endometrial carcinoma. Biomed Pharmacothe. 2018;107:918–928.
   PubMed Web of Science ®Google Scholar
• Agarwal S, Smith KP, Zhou Y, et al. Cdt1 stabilizes kinetochore-microtubule attachments via an aurora B kinase-dependent mechanism. J Cell Biol. 2018;217(10):3446–3463.
   PubMed Web of Science ®Google Scholar
• Karavias D, Maroulis I, Papadaki H, et al. Overexpression of CDT1 Is a predictor of poor survival in patients with hepatocellular carcinoma. J Gastrointest Surg. 2016;20(3):568–579.
   PubMed Web of Science ®Google Scholar
• Mahadevappa R, Neves H, Yuen SM, et al. The prognostic significance of cdc6 and cdt1 in breast cancer. Sci Rep. 2017;7(1):985.
   PubMedGoogle Scholar
• Kosaka T, Yasumizu Y, Miyazaki Y, et al. Potent increased risk of the initiation of DNA replication in human prostate cancer with the use of 5α-reductase inhibitors. Am J Clin Exp Urol. 2014;2(2):136–144.
   PubMedGoogle Scholar
• Guan H, Zhu T, Wu S, et al. Long noncoding RNA LINC00673-v4 promotes aggressiveness of lung adenocarcinoma via activating WNT/β-catenin signaling. Proc Natl Acad Sci U S A. 2019;116(28):14019–14028.
   PubMed Web of Science ®Google Scholar
• Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta C(T)) Method. Methods (San Diego. Calif). 2001;25(4):402–408.
   Google Scholar
• Cheng Q, Zhang M, Zhang M, et al. Long non-coding RNA LOC285194 regulates vascular smooth muscle cell apoptosis in atherosclerosis. Bioengineered. 2020;11(1):53–60.
   PubMed Web of Science ®Google Scholar
• Ming-Yan Y, Jing Z, Shu-Qin G, et al. Liraglutide inhibits the apoptosis of human nucleus pulposus cells induced by high glucose through PI3K/Akt/caspase-3 signaling pathway. Biosci Rep. 2019;39(8). DOI:10.1042/BSR20190109
   PubMedGoogle Scholar
• Liang Z, Xu J, Ma Z, et al. MiR-187 suppresses non-small-cell lung cancer cell proliferation by targeting FGF9. Bioengineered. 2020;11(1):70–80.
   PubMed Web of Science ®Google Scholar
• Ding M, Jiang CY, Zhang Y, et al. SIRT7 depletion inhibits cell proliferation and androgen-induced autophagy by suppressing the AR signaling in prostate cancer. J Exp Clin Cancer Res. 2020;39(1):28.
   PubMed Web of Science ®Google Scholar
• Han B, Ge Y, Cui J, et al. Down-regulation of lncRNA DNAJC3-AS1 inhibits colon cancer via regulating miR-214-3p/LIVIN axis. Bioengineered. 2020;11(1):524–535.
   PubMed Web of Science ®Google Scholar
• Jiang Y, Liu H, Yu H, et al. Circular RNA calm4 regulates hypoxia-induced pulmonary arterial smooth muscle cells pyroptosis via the Circ-Calm4/miR-124-3p/PDCD6 axis. Arterioscler Thromb Vasc Biol. 2021;41(5):1675–1693.
   PubMed Web of Science ®Google Scholar
• Liu K, Zhao D, Wang D. LINC00528 regulates myocardial infarction by targeting the miR-143-3p/COX-2 axis. Bioengineered. 2020;11(1):11–18.
   PubMed Web of Science ®Google Scholar
• Jathar S, Kumar V, Srivastava J, et al. Technological developments in lncRNA Biology. Adv Exp Med Biol. 2017;1008:283–323.
   PubMed Web of Science ®Google Scholar
• Xu J, Bai J, Zhang X, et al. A comprehensive overview of lncRNA annotation resources. Brief Bioinform. 2017;18(2):236–249.
   PubMed Web of Science ®Google Scholar
• Peng WX, Koirala P, Mo YY. LncRNA-mediated regulation of cell signaling in cancer. Oncogene. 2017;36(41):5661–5667.
   PubMed Web of Science ®Google Scholar
• Liu S, Li J, Kang L, et al. Degradation of long non-coding RNA-CIR decelerates proliferation, invasion and migration, but promotes apoptosis of osteosarcoma cells. Cancer Cell Int. 2019;19(1):349.
   PubMed Web of Science ®Google Scholar
• Zhai XQ, Meng FM, Hu SF, et al. Mechanism of LncRNA ROR promoting prostate cancer by regulating Akt. Eur Rev Med Pharmacol Sci. 2019;23(5):1969–1977.
   PubMed Web of Science ®Google Scholar
• Yang J, Li C, Mudd A, et al. LncRNA PVT1 predicts prognosis and regulates tumor growth in prostate cancer. Biosci Biotechnol Biochem. 2017;81(12):2301–2306.
   PubMed Web of Science ®Google Scholar
• Prensner JR, Sahu A, Iyer MK, et al. The IncRNAs PCGEM1 and PRNCR1 are not implicated in castration resistant prostate cancer. Oncotarget. 2014;5(6):1434–1438.
   PubMedGoogle Scholar
• Zhang S, Li Z, Zhang L, et al. MEF2‑activated long non‑coding RNA PCGEM1 promotes cell proliferation in hormone‑refractory prostate cancer through downregulation of miR‑148a. Mol Med Rep. 2018;18(1):202–208.
   PubMed Web of Science ®Google Scholar
• He JH, Zhang JZ, Han ZP, et al. Reciprocal regulation of PCGEM1 and miR-145 promote proliferation of LNCaP prostate cancer cells. J Exp Clin Cancer Res. 2014;33(1):72.
   PubMedGoogle Scholar
• Luo Y, Li H, Huang H, et al. Integrated analysis of ceRNA network in hepatocellular carcinoma using bioinformatics analysis. Medicine (Baltimore). 2021;100(22):e26194.
   PubMed Web of Science ®Google Scholar
• Varma D, Chandrasekaran S, Sundin LJ, et al. Recruitment of the human Cdt1 replication licensing protein by the loop domain of hec1 is required for stable kinetochore-microtubule attachment. Nat Cell Biol. 2012;14(6):593–603.
   PubMed Web of Science ®Google Scholar
• Milhollen MA, Narayanan U, Soucy TA, et al. Inhibition of NEDD8-activating enzyme induces rereplication and apoptosis in human tumor cells consistent with deregulating CDT1 turnover. Cancer Res. 2011;71(8):3042–3051.
   PubMed Web of Science ®Google Scholar
• Petropoulou C, Kotantaki P, Karamitros D, et al. Cdt1 and geminin in cancer: markers or triggers of malignant transformation? Front Biosci. 2008;13(13):4485–4494.
   PubMedGoogle Scholar
• Cao Y, Li P, Wang H, et al. SIRT3 promotion reduces resistance to cisplatin in lung cancer by modulating the FOXO3/CDT1 axis. Cancer Med. 2021;10(4):1394–1404.
   PubMed Web of Science ®Google Scholar
• Zhai Y, Cheng E, Wu H, et al. Open-ringed structure of the Cdt1-Mcm2-7 complex as a precursor of the MCM double hexamer. Nat Struct Mol Biol. 2017;24(3):300–308.
   PubMed Web of Science ®Google Scholar